Retroviral protease inhibiting compounds

US7279582B2 · kind B2 · utility

Assignee

• Abbott Laboratories · US

Inventors

• Eric J. Stoner · Kenosha, US
• Arthur J. Cooper · Mentor, US
• Lawrence Kolaczkowski · Gurnee, US
• Ketan M. Patel · Arlington Heights, US
• Hing L. Sham · South San Francisco, US
• Daniel W. Norbeck · Crystal Lake, US
• Xiaoqi Chen · Palo Alto, US
• David A. Betebenner · Lawrenceville, US
• Thomas R. Herrin · Waukegan, US
• Gondi N. Kumar · Round Lake Beach, US
• Stephen Condon · Kenosha, US
• Daniel A. Dickman · Grayslake, US
• Patricia A. Oliver · Lindenhurst, US
• Jien-Heh J. Tien · Libertyville, US

Key dates

• Filing date: Oct 25, 2002
• Grant date: Oct 9, 2007
• Expiry date: Oct 25, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A compound of the formula:is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.